NCT06675396

Brief Summary

By using genetic information we could predict the prevalence of mood disorder and response to treatment.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
33mo left

Started Dec 2024

Longer than P75 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Dec 2024Dec 2028

First Submitted

Initial submission to the registry

November 4, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 5, 2024

Completed
26 days until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

November 5, 2024

Status Verified

November 1, 2024

Enrollment Period

2.1 years

First QC Date

November 4, 2024

Last Update Submit

November 4, 2024

Conditions

Chronic Kidney Disease(CKD)Depression

Keywords

CKDMood disorder

Outcome Measures

Primary Outcomes (1)

  • Prevalence of depression

    Prevalence of depression

    10 years

Study Arms (1)

chronic kidney with mood disorder

Patients developed mood disorder after chronic kidney disease development

Other: Antidepressants

Interventions

AntidepressantsOTHER

control

chronic kidney with mood disorder

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with CKD without history of mood disorder

You may qualify if:

  • CKD patients aged 18 to 90 years

You may not qualify if:

  • no CKD patients, aged below 18 or above 90 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITH DNA

Whole genome analysis

MeSH Terms

Conditions

Renal Insufficiency, ChronicDepressionMood Disorders

Interventions

Antidepressive Agents

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavioral SymptomsBehaviorMental Disorders

Intervention Hierarchy (Ancestors)

Psychotropic DrugsCentral Nervous System AgentsTherapeutic UsesPharmacologic ActionsChemical Actions and Uses

Central Study Contacts

Jun Young Lee Lee Jun Young Professor

CONTACT

800-555-5555junyoung07@yonsei.ac.kr

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 4, 2024

First Posted

November 5, 2024

Study Start

December 1, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2028

Last Updated

November 5, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share